Advances in leishmaniasis

This publication has 190 references indexed in Scilit:

• Randomized, Double-Blind Clinical Trial of Topical Imiquimod 5% with Parenteral Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis in Peru
  Clinical Infectious Diseases, 2005
• Efficacy of Thermotherapy to Treat Cutaneous Leishmaniasis Caused byLeishmania tropicain Kabul, Afghanistan: A Randomized, Controlled Trial
  Clinical Infectious Diseases, 2005
• Old World Leishmaniasis: An Emerging Infection among Deployed US Military and Civilian Workers
  Clinical Infectious Diseases, 2004
• Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern Sudan
  Clinical Infectious Diseases, 2004
• Single‐Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study
  Clinical Infectious Diseases, 2003
• The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure
  The Journal of Experimental Medicine, 2001
• Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis
  Journal of Dermatological Treatment, 2001
• Competence of the Human Host as a Reservoir forLeishmania chagasi
  The Journal of Infectious Diseases, 2000
• Inhibition of Interferon‐γ Signaling byLeishmania donovani
  The Journal of Infectious Diseases, 2000
• Evaluation of diamidine compound (pentamidine isethionate) in the treatment of resistant cases of kala-azar occurring in North Bihar, India
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1983